1
|
Ma P, Toussaint B, Roberti EA, Scornet N, Santos Silva A, Castillo Henríquez L, Cadasse M, Négrier P, Massip S, Dufat H, Hammad K, Baraldi C, Gamberini MC, Richard C, Veesler S, Espeau P, Lee T, Corvis Y. New Lidocaine-Based Pharmaceutical Cocrystals: Preparation, Characterization, and Influence of the Racemic vs. Enantiopure Coformer on the Physico-Chemical Properties. Pharmaceutics 2023; 15:pharmaceutics15041102. [PMID: 37111588 PMCID: PMC10142540 DOI: 10.3390/pharmaceutics15041102] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/29/2022] [Revised: 03/22/2023] [Accepted: 03/23/2023] [Indexed: 04/03/2023] Open
Abstract
This study describes the preparation, characterization, and influence of the enantiopure vs. racemic coformer on the physico-chemical properties of a pharmaceutical cocrystal. For that purpose, two new 1:1 cocrystals, namely lidocaine:dl-menthol and lidocaine:d-menthol, were prepared. The menthol racemate-based cocrystal was evaluated by means of X-ray diffraction, infrared spectroscopy, Raman, thermal analysis, and solubility experiments. The results were exhaustively compared with the first menthol-based pharmaceutical cocrystal, i.e., lidocaine:l-menthol, discovered in our group 12 years ago. Furthermore, the stable lidocaine/dl-menthol phase diagram has been screened, thoroughly evaluated, and compared to the enantiopure phase diagram. Thus, it has been proven that the racemic vs. enantiopure coformer leads to increased solubility and improved dissolution of lidocaine due to the low stable form induced by menthol molecular disorder in the lidocaine:dl-menthol cocrystal. To date, the 1:1 lidocaine:dl-menthol cocrystal is the third menthol-based pharmaceutical cocrystal, after the 1:1 lidocaine:l-menthol and the 1:2 lopinavir:l-menthol cocrystals reported in 2010 and 2022, respectively. Overall, this study shows promising potential for designing new materials with both improved characteristics and functional properties in the fields of pharmaceutical sciences and crystal engineering.
Collapse
Affiliation(s)
- Panpan Ma
- CNRS, INSERM, UTCBS, Chemical and Biological Technologies for Health Group, Université Paris Cité, F-75006 Paris, France
| | - Balthazar Toussaint
- CNRS, INSERM, UTCBS, Chemical and Biological Technologies for Health Group, Université Paris Cité, F-75006 Paris, France
- Département Recherche et Développement Pharmaceutique (DRDP), Agence générale des Équipements et Produits de Santé, AP-HP, F-75005 Paris, France
| | - Enrica Angela Roberti
- CNRS, INSERM, UTCBS, Chemical and Biological Technologies for Health Group, Université Paris Cité, F-75006 Paris, France
| | - Noémie Scornet
- CNRS, INSERM, UTCBS, Chemical and Biological Technologies for Health Group, Université Paris Cité, F-75006 Paris, France
| | - Axel Santos Silva
- CNRS, INSERM, UTCBS, Chemical and Biological Technologies for Health Group, Université Paris Cité, F-75006 Paris, France
| | - Luis Castillo Henríquez
- CNRS, INSERM, UTCBS, Chemical and Biological Technologies for Health Group, Université Paris Cité, F-75006 Paris, France
| | - Monique Cadasse
- Département Physico-Chimie du Médicament, Unité Pédagogique de Chimie Analytique, Physique et Toxicologie, Faculté de Santé, Université Paris Cité, 4 Avenue de l’Observatoire, F-75006 Paris, France
| | - Philippe Négrier
- Laboratoire Ondes et Matière d’Aquitaine, Université de Bordeaux, UMR 5798, F-33400 Talence, France
| | - Stéphane Massip
- CNRS, INSERM, IECB, Université de Bordeaux, UAR 3033, F-33600 Pessac, France
| | - Hanh Dufat
- CiTCoM, Université Paris Cité, UMR CNRS 8038, F-75006 Paris, France
| | - Karim Hammad
- CiTCoM, Université Paris Cité, UMR CNRS 8038, F-75006 Paris, France
| | - Cecilia Baraldi
- Department of Life Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy
| | | | - Cyrille Richard
- CNRS, INSERM, UTCBS, Chemical and Biological Technologies for Health Group, Université Paris Cité, F-75006 Paris, France
| | - Stéphane Veesler
- CNRS, Aix-Marseille Université, CINaM (Centre Interdisciplinaire de Nanosciences de Marseille), Campus de Luminy, CEDEX 09, F-13288 Marseille, France
| | - Philippe Espeau
- CNRS, INSERM, UTCBS, Chemical and Biological Technologies for Health Group, Université Paris Cité, F-75006 Paris, France
| | - Tu Lee
- Department of Chemical and Materials Engineering, National Central University, Taoyuan 320317, Taiwan
| | - Yohann Corvis
- CNRS, INSERM, UTCBS, Chemical and Biological Technologies for Health Group, Université Paris Cité, F-75006 Paris, France
- Correspondence:
| |
Collapse
|
2
|
Crystallization of Form II Paracetamol with the Assistance of Carboxylic Acids toward Batch and Continuous Processes. Pharmaceutics 2022; 14:pharmaceutics14051099. [PMID: 35631685 PMCID: PMC9147162 DOI: 10.3390/pharmaceutics14051099] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/08/2022] [Revised: 05/12/2022] [Accepted: 05/17/2022] [Indexed: 02/04/2023] Open
Abstract
Form II paracetamol has captured the interest of researchers due to its improved compressibility. However, its low stability has made it difficult to be produced on a large scale with good reproducibility. In the present study, the selective polymorphic formation of paracetamol was carried out by cooling crystallization with four types of additives: adipic acid, fumaric acid, oxalic acid, and succinic acid. It was found that: (1) the more additives that were added, the higher the probability of forming Form II paracetamol; (2) Form II paracetamol could be induced by seeding the paracetamol aqueous solution with Form II paracetamol and fumaric acid crystals, and not the other three carboxylic acids; (3) a new solution complex of paracetamol–oxalic acid, evidenced by the solubility diagram, was responsible for the selective nucleation of Form II paracetamol in the oxalic acid aqueous solution; and (4) the range of the degree of supersaturation for nucleating Form II paracetamol was extended with the assistance of oxalic acid or fumaric acid. In large-scale crystallization, Form II paracetamol was produced by the continuous crystallization of 44 mg of paracetamol/mL in 50 wt% of fumaric acid aqueous solution with a flow rate of 150 mL/min.
Collapse
|
4
|
Lee HL, Vasoya JM, Cirqueira MDL, Yeh KL, Lee T, Serajuddin ATM. Continuous Preparation of 1:1 Haloperidol-Maleic Acid Salt by a Novel Solvent-Free Method Using a Twin Screw Melt Extruder. Mol Pharm 2017; 14:1278-1291. [PMID: 28245127 DOI: 10.1021/acs.molpharmaceut.7b00003] [Citation(s) in RCA: 34] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/20/2023]
Abstract
Salts are generally prepared by acid-base reaction in relatively large volumes of organic solvents, followed by crystallization. In this study, the potential for preparing a pharmaceutical salt between haloperidol and maleic acid by a novel solvent-free method using a twin-screw melt extruder was investigated. The pH-solubility relationship between haloperidol and maleic acid in aqueous medium was first determined, which demonstrated that 1:1 salt formation between them was feasible (pHmax 4.8; salt solubility 4.7 mg/mL). Extrusion of a 1:1 mixture of haloperidol and maleic acid at the extruder barrel temperature of 60 °C resulted in the formation of a highly crystalline salt. The effects of operating temperature and screw configuration on salt formation were also investigated, and those two were identified as key processing parameters. Salts were also prepared by solution crystallization from ethyl acetate, liquid-assisted grinding, and heat-assisted grinding and compared with those obtained by melt extrusion by using DSC, PXRD, TGA, and optical microscopy. While similar salts were obtained by all methods, both melt extrusion and solution crystallization yielded highly crystalline materials with identical enthalpies of melting. During the pH-solubility study, a salt hydrate form was also identified, which, upon heating, converted to anhydrate similar to that obtained by other methods. There were previous reports of the formation of cocrystals, but not salts, by melt extrusion. 1H NMR and single-crystal X-ray diffraction confirmed that a salt was indeed formed in the present study. The haloperidol-maleic acid salt obtained was nonhygroscopic in the moisture sorption study and converted to the hydrate form only upon mixing with water. Thus, we are reporting for the first time a relatively simple and solvent-free twin-screw melt extrusion method for the preparation of a pharmaceutical salt that provides material comparable to that obtained by solution crystallization and is amenable to continuous manufacturing and easy scale up.
Collapse
Affiliation(s)
- Hung Lin Lee
- Department of Chemical and Materials Engineering, National Central University , 300 Jhong-Da Road, Jhong-Li District, Taoyuan City 32001, Taiwan R.O.C.,Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University , 8000 Utopia Parkway, Queens, New York 11439, United States
| | - Jaydip M Vasoya
- Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University , 8000 Utopia Parkway, Queens, New York 11439, United States
| | - Marilia de Lima Cirqueira
- Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University , 8000 Utopia Parkway, Queens, New York 11439, United States
| | - Kuan Lin Yeh
- Department of Chemical and Materials Engineering, National Central University , 300 Jhong-Da Road, Jhong-Li District, Taoyuan City 32001, Taiwan R.O.C
| | - Tu Lee
- Department of Chemical and Materials Engineering, National Central University , 300 Jhong-Da Road, Jhong-Li District, Taoyuan City 32001, Taiwan R.O.C
| | - Abu T M Serajuddin
- Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University , 8000 Utopia Parkway, Queens, New York 11439, United States
| |
Collapse
|